Research Explorer uses third party
cookies
to generate statistics about the use of the site. For that we need your permission.
I agree
Close
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Dominic De Groote
Profile
Projects
Publications
Activities
22
Results
As
Promotor
01 July 2008 → Ongoing
DiscoverE
Funding: Regional and community funding: Industrial Research Fund
01 October 2020 → Ongoing
DiscoverE
Funding: Regional and community funding: Industrial Research Fund
As
Copromotor
01 September 2014 → 31 December 2016
An Opportunity to Develop Novel Inhibitors of Invasion for the Treatment of Metastatic Cancers
Funding: Regional and community funding: Industrial Research Fund
01 January 2011 → 31 December 2014
Circumventing the Biological Obstacles of anti-inflammatory Glucocorticoid Therapy
Funding: Regional and community funding: various
15 August 2014 → 31 March 2018
Exploiting novel GR biology as an opportunity to develop safer anti-inflammatory drugs
Funding: Regional and community funding: Industrial Research Fund
01 January 2013 → 31 December 2016
Fighting infectious diseases with combination therapy: targetting sociomicrobiological processes to circumvent antimicrobial resistance
Funding: Regional and community funding: various
01 August 2012 → 30 April 2014
Hit-to-lead Evaluation of Chalcone Analogs Useful for Anti-Invasive Cancer Therapy
Funding: Regional and community funding: Industrial Research Fund
15 August 2014 → 15 August 2017
Opportunity to develop novel HDAC6 inhibitors for therapeutic use
Funding: Regional and community funding: Industrial Research Fund
01 January 2012 → 31 December 2015
STRETCH: mechanotransduction in osteoimmunology: an innovative approach towards effective drug for rheumatic diseases
Funding: Regional and community funding: various
01 October 2021 → Ongoing
Targeting transcription factor addiction in acute leukemia (TaTFAL)
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 31 December 2017
Unravelling the pharmaceutical potential of receptor heterodimers for therapeutic intervention in CNS disorders.
Funding: Regional and community funding: various
As
IOF Business Developer
01 August 2018 → 31 August 2021
A SMART technology for the continuous manufacturing of lyophilized orally disintegrating tablets
Funding: Regional and community funding: Industrial Research Fund
15 June 2020 → 28 February 2022
Accellerating towards clinical validation of Galsome nanovaccines
Funding: Regional and community funding: Industrial Research Fund
15 July 2021 → Ongoing
An innovative class of ionizable lipids for use in lipid nanoparticle based RNA therapeutics and vaccines
Funding: Regional and community funding: Industrial Research Fund
15 July 2021 → Ongoing
BioGelator for local immunotherapy
Funding: Regional and community funding: Industrial Research Fund
01 July 2008 → Ongoing
DiscoverE
15 October 2021 → Ongoing
Extending the Amalus drug discovery program: validation studies for immuno-oncological and fibrosis indications to increase the IP and investment value
Funding: Regional and community funding: Industrial Research Fund
01 October 2021 → Ongoing
IonKey/MSTM system: enhanced ‘plug and play’ mass spectrometry for ultrasensitive quantification of small molecules in small sample volumes in life sciences, with applications in the development and valorisation of endotoxin-mitigation strategies (feed additives) and anti-inflammatory drugs (pharma) in livestock.
Funding: Regional and community funding: Industrial Research Fund
01 April 2019 → 31 August 2020
IP strenghtening for MIDRIX, a unique manufacturing process for dendritic cell immunotherapy in solid cancers
Funding: Regional and community funding: Industrial Research Fund
01 August 2019 → 31 March 2022
Mechanistic & Empirical Modeling for the PHarmaceutical InduStry
Funding: Regional and community funding: Industrial Research Fund
01 April 2019 → 31 March 2020
Strengthening the UGent patent position on an improved cultivation method for adoptive cell therapies (immuno-oncology).
Funding: Regional and community funding: Industrial Research Fund
15 April 2022 → Ongoing
The generation of bona fide T cell precursors for cell therapy
Funding: Regional and community funding: Industrial Research Fund
